ARTICLE | Company News
Ipsogen SAS, INSERM, Institut Gustave Roussy, Assistance Publique - Hopitaux de Paris deal
April 10, 2006 7:00 AM UTC
The institute, hospital and INSERM granted Ipsogen exclusive worldwide rights to use a mutant form of the JAK2 gene to develop diagnostics for myeloproliferative disorders. Financial terms were not d...